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Dev. 18, 1970 (2004 Tourette's syndrome (TS) is a genetically influenced developmental neuropsychiatric disorder characterized by chronic vocal and motor tics. We studied Slit and Trk-like 1 (SLITRK1) as a candidate gene on chromosome 13q31.1 because of its proximity to a de novo chromosomal inversion in a child with TS. Among 174 unrelated probands, we identified a frameshift mutation and two independent occurrences of the identical variant in the binding site for microRNA hsa-miR-189. These variants were absent from 3600 control chromosomes. SLITRK1 mRNA and hsa-miR-189 showed an overlapping expression pattern in brain regions previously implicated in TS. Wild-type SLITRK1, but not the frameshift mutant, enhanced dendritic growth in primary neuronal cultures. Collectively, these findings support the association of rare SLITRK1 sequence variants with TS.
TS is a potentially debilitating developmental neuropsychiatric disorder, characterized by the combination of persistent vocal and motor tics, that affects as many as 1 in 100 individuals (1, 2) . A substantial portion of clinically referred TS patients also suffer from obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), or depression (3) . A TS spectrum of disorders that includes chronic vocal or motor tics as well as tic-related OCD and ADHD is widely recognized. Phenomenological and neurobiological evidence also supports the inclusion of some habit disorders, including trichotillomania (TTM), in this phenotypic spectrum (4, 5) . Several decades of investigation have confirmed a substantial genetic contribution to TS (6) . Early segregation analyses suggested that the disorder was inherited as a rare, autosomal dominant trait (7) . However, more recent studies have supported poly-or oligogenic inheritance (8) . Genome-wide analysis of linkage has implicated intervals on chromosomes 4, 5, 8, 11, and 17 (9-12) , but to date no diseaserelated mutations have been identified. These investigations have been complicated by a phenotype that typically decreases in severity with age, a high population prevalence of transient tics, and symptoms that overlap with common disorders such as ADHD and OCD (13) . In addition, marked locus heterogeneity, gene-environment interactions, and the further confounding of assortative mating (14, 15) have all likely hindered gene-mapping efforts.
We focused on a rare subset of TS patients with chromosomal anomalies to circumvent some of these obstacles and identify candidate genes for intensive mutational screening. Such a strategy provides the opportunity to characterize functional sequence variants largely irrespective of their mode of inheritance. We identified a patient presenting with TS and ADHD and carrying a de novo chromosome 13 inversion, inv(13)(q31.1;q33.1) (16) . There was no family history of tics, TS, OCD, TTM, or ADHD ( Fig.  1 ). Genotyping with multiple short tandem repeat (STR) markers confirmed paternity (16) (table S1). The co-occurrence of a de novo chromosomal abnormality with the only known case of TS in the pedigree led us to fine map the rearrangement with the use of fluorescence in situ hybridization (FISH). We found that bacterial artificial chromosomes (BACs) RP11-375K12 and RP11-255P5 span the 13q31.1 and 13q33.1 breakpoints, respectively ( Fig. 1 , C to F, and table S2).
Three genes map within 500 kilobases (kb) of these two breakpoints (Fig. 1 , E and F). Of these, Slit and Trk-like family member 1 (SLITRK1), encoding a single-pass transmembrane protein with two leucine-rich repeat (LRR) motifs in its extracellular domain, was considered the strongest candidate for further study because of its high relative expression in brain regions previously implicated in TS and its suggested role in neurite outgrowth (17, 18) . ERCC5 and SLC10A2, mapping immediately centromeric and telomeric, respectively, to the 13q33.1 breakpoint, were not excluded as candidates but were considered less likely alternatives because both have been shown to lead to disorders with no known relationship to TS (19, 20) (Fig. 1F) .
The 13q31.1 chromosomal breakpoint mapped well outside the coding region of SLITRK1, and direct sequencing of the transcript in the affected individual showed no abnormalities (16) . Consequently, we hypothesized that the expression of the gene might be altered by a position effect (21) . However, the genomic organization of the transcript in a single coding exon, in conjunction with its low levels of expression in peripheral lymphocytes, precluded our direct quantitative assessment of SLITRK1 mRNA in the patient versus controls.
We reasoned, however, that if altered SLITRK1 function contributed to the risk for TS in the patient carrying the inversion, we would expect a subset of TS patients to have mutations in this gene. Accordingly, we screened SLITRK1 in 174 affected individuals (16) . We identified one proband, diagnosed with TS and ADHD, who possessed a single-base deletion in the coding region leading to a frameshift, predicted to result in a truncated protein lacking a substantial portion of the second LRR as well as its transmembrane and intracellular domains (Fig. 2) .
Four additional family members were ascertained and genotyped (16) . The mutation was found in the patient_s mother, affected with TTM, but not in the two at-risk maternal uncles or in the maternal grandmother, all of whom were unaffected ( Fig. 2A) . Moreover, the mutation was not present in 3600 control chromosomes (16) . Finally, no truncating mutations or apparently deleterious variants were identified upon comprehensive mutation screening of the SLITRK1 coding region in 253 controls (16) (table S4) .
In addition to this frameshift mutation, the identical noncoding sequence variant (var321) was identified in two apparently unrelated individuals with TS and obsessive-compulsive (OC) symptoms. The single-base change maps to the 3 ¶ untranslated region (UTR) of the transcript and corresponds to a highly conserved nucleotide within the predicted binding site for the human microRNA (miRNA) hsa-miR-189, one of two mature miRNAs derived from the hsa-miR-24 precursor (22, 23) (Fig. 3 , A to D, and table S6). This variant was absent from 4296 control chromosomes, demonstrating a statistically significant association with TS (P 0 0.0056; Fisher_s exact test) and raising the question of whether the two occurrences might represent independent genetic events. To evaluate this, we genotyped STRs and single-nucleotide polymorphisms in close proximity to var321. In each case, the variant was found to reside on a distinct haplotype, with distinguishing polymorphisms 83.5 kb centromeric and 3.8 kb telomeric to the variant (table S7), providing strong evidence that the two occurrences arose independently. With a conservative estimate of the mutation frequency at this base (È10 j7 ), the likelihood of identifying an independent recurrence of the variant by chance among 346 chromosomes is remote (P 0 0.000056) (16) .
DNA samples from the families of both probands carrying var321 were sought. Samples were unavailable from family 3, in which both the mother and father were affected; the mother had a history of chronic motor tics and the father suffered chronic vocal and motor tics, OC symptoms, and hair pulling. In family 4, only the proband carried a formal diagnosis; however, her mother, sister, a maternal grandfather, and a paternal uncle all had a history of tics, subclinical OC symptoms, or both (16) . DNA was obtained from the immediate family, and its analysis showed that the proband and her mother carried the variant (16) .
The var321 replaces a G:U wobble base pair with an A:U Watson-Crick pairing at position 9 in the miRNA binding domain. The extent of conservation of this G:U pairing, in both SLITRK1 3 ¶UTR and miR-189 (Fig. 3 , B and C), as well as evidence that G:U wobble base pairs inhibit miRNA-mediated protein repression to a greater degree than would be expected on the basis of their thermodynamic properties alone (24) , suggested that var321 might affect SLITRK1 expression. To test this hypothesis, we inserted the full-length SLITRK1 3 ¶UTR downstream of a luciferase reporter gene and transfected the construct into Neuro2a (N2a) cells. In the presence of miR-189, the expression of luciferase was significantly reduced (Fig. 3 , B to D, and table S8), confirming the functional potential of the mRNA-miRNA duplex. We next inserted the 3 ¶UTR containing var321 and found that the sequence variant resulted in a modest but statistically significant and dose-dependent further repression of luciferase expression compared with that of the wild type ( Fig. 3G and  table S8 ).
On the basis of the hypothesis that an altered interaction of SLITRK1 mRNA with miR-189 contributed to TS in the patients carrying var321, we reasoned that SLITRK1 and miR-189 expression should overlap in the developing brain. In situ hybridization in postnatal mouse demonstrated that Slitrk1 mRNA is expressed in the neocortex, hippocampus, thalamic and subthalamic nuclei, striatum, globus pallidus, and cerebellum, in agreement with earlier findings (Fig. 4, A and B) (17) . We observed mmu-miR-189 expression in the developing neocortex, hippocampus, thalamus, basal ganglia, and cerebellum, overlapping substantially with SLITRK1 ( Fig. 4C and fig.  S1 ). In fetal human brain at 20 weeks of gestation, we detected SLITRK1 mRNA in multiple regions, including the developing neocortical plate, subplate zone, striatum, globus pallidus, thalamus, and subthalamus ( fig. S2 ). hsa-miR-189 was highly expressed in the cortical plate and intermediate zone ( fig. S2 ), but not in the basal ganglia or thalamus. Overall, our results demonstrate a developmentally regulated and overlapping pattern of expression of SLITRK1 mRNA and miR-189 in the neuroanatomical circuits most commonly implicated in TS, OCD, and habit formation (25) .
Among the six known members of the SLIT and TRK-like gene family, SLITRK1 is unique in that it lacks tyrosine phosphorylation sites in its short intracellular domain. In this respect, it resembles the SLIT proteins, multifunctional secreted molecules with roles in axon repulsion (26) as well as dendritic patterning in the cerebral cortex (27) . Given the high levels of cortical expression of SLITRK1, we investigated its effects on dendritic growth and morphology. Cortical pyramidal neurons were placed in culture after in utero electroporation of mouse embryos with wild-type human SLITRK1 or the frameshift mutant, along with green fluorescent protein (GFP) (Fig. 4 , D to F). At 2 days in vitro (DIV), dendrites expressing wild-type SLITRK1 were significantly longer than those expressing the frameshift (P 0 0.002; Student_s t test). By 4 and 6 DIV, dendrites expressing wild-type SLITRK1 were significantly longer than either comparison group, control or frameshift ( Fig. 4G and table S9 ). These findings resemble, in part, the phenotype elicited by the exposure of cortical neurons to SLIT1 (27) and suggest both that SLITRK1 may promote dendritic growth and that the frameshift mutation likely results in a loss of function.
For many complex disorders, the discovery of rare mutations in small subsets of patients has had a major impact in the identification of fundamental pathways that underlie disease pathogenesis. Further study of this new candidate gene, SLITRK1, may serve a similar role in the effort to better understand TS at the molecular and cellular level. (proband 1) is a Caucasian boy with a history of tics beginning at age 2, consisting of eye blinking and head turning, followed by shoulder shrugs lasting a few months. He was diagnosed with TS at age 3 due to a full body tic that his parents mistook for a seizure.
An electroencephalogram performed at that time was normal. The patient's subsequent history included multiple facial, shoulder and head tics, and some "just-right" behaviors.
He also had a history of coughing, throat clearing, sniffing, echolalia and palilalia. The patient was evaluated by one of the authors (CAM) at 6 years of age. At that time, on the Yale Global Tic Severity Scale (YGTSS) his "worst ever" scores were 11/25 for motor and 8/25 for vocal tics, yielding a "worst ever" total tic score of 19/50, which places him in the mild to moderate range of severity. Based on a standardized research evaluation, the patient was diagnosed with definite TS, mild intensity, and attention deficit hyperactivity disorder (ADHD), combined type, moderate intensity. He had no significant obsessive-compulsive (OC) symptoms and no other psychiatric diagnoses.
The patient had previously been diagnosed with a de novo chromosome 13 inversion found incidentally on prenatal testing performed because his mother was a carrier for an unrelated disorder. The mother was noted to smoke 1 pack of cigarettes per day during pregnancy, but there were no other known exposures in utero. His early developmental history was unremarkable. He was the product of a normal spontaneous delivery at 38 weeks and reached his developmental milestones in the first years of life as expected, with the exception of a slight delay in fine motor skills, which were thought to be normal at the time of the 6-year exam. There was no evidence of mental retardation or learning disability.
The patient's past medical history was otherwise unremarkable based on parental report. There was no history of biliary malabsorption, excessive sun sensitivity, or cancer. On physical exam, there was no evidence of dysmorphology or concurrent medical illness.
The patient's parents were evaluated as part of the research study and neither met diagnostic criteria for TS, tics, TTM (trichotillomania), ADHD or obsessive compulsive disorder (OCD). There was a history of ADHD reported in a maternal cousin. There was no history of tics, TS, TTM, or OCD in the extended family. At the time of the initial research evaluation, the patient's family reported that his "worst ever" tics were experienced between the ages of 5 to 6 years. By history, he received a YGTSS total tic score of 24 out of 50 suggesting moderate symptoms. He exhibited both simple and complex motor tics including eye blinking, turning up the corner of his mouth, jaw stretching, lifting his chin up, side-to-side and up-and-down head movements, and kicking out his leg when sitting. His vocal tics included throat clearing and tongue clicking. Based on consensus research criteria, he was diagnosed with definite TS and definite ADHD, combined type.
The proband's past medical history was notable for a head injury with loss of consciousness at 6 years of age. This injury was subsequent to the onset of both ADHD symptoms and the clinical recognition of tics. He suffered multiple ear infections, and was status-post myringotomy at age 2.
The patient's early developmental history was unremarkable. There were no preor peri-natal complications and he met his developmental milestones appropriately.
There was no evidence of mental retardation.
The family history was remarkable for hair pulling by the patient's mother beginning in childhood and continuing to the present day. She first developed symptoms of pulling scalp hair, eyebrows and eyelashes in her early teens. She developed a bald spot and was given a wig to wear at school to avoid ridicule. She recalls that her symptoms were most severe during adolescence and resulted in "wiping out" her eyebrows and eyelashes during that period of time. The hair pulling and consequent hair loss resulted in significant distress when the symptoms were at their peak. She was brought to medical attention by her parents for her symptoms. Since adolescence, her symptoms continued with a waxing and waning course, though overall the intensity was reported to have decreased with time, except during periods of stress. She did not report experiencing a rising sense of tension prior to the pulling of her hair, but did note "justright" sensations involving the identification of the "correct hair" to pull and relief when completing the act. She had never suffered from other abnormal movements or vocalizations. She denies any current symptoms of OCD and denies any history of ADHD.
The proband's maternal grandfather was deceased and it was recalled that he had a "facial tic" by some family members which consisted of chewing the inside of his cheek. The maternal grandmother had no history of TS-spectrum conditions. Neither maternal uncle carried a history of TS, ADHD, OCD or tics. One maternal aunt was assigned affected status unknown as she declined evaluation and participation in the genetic study. A second maternal aunt agreed to be interviewed and was asymptomatic with no history of ADHD, tics, OCD or TS. However, she subsequently declined participation in the genetic study.
Family 3:
The proband is a Caucasian male who originally developed motor tics at age 9 that consisted of head jerks and facial grimaces. He reported the onset of nose twitching, arm flexing and foot stomping at age 10. He subsequently developed vocal tics that included coughing, throat clearing, sniffing and making "animal noises." He was seen clinically for these difficulties at age 14, noted significant distress as a consequence of the chronic symptoms, and was given a diagnosis of TS.
During his initial evaluation for research participation at age 15, the patient was noted to have eye blinking, facial grimaces, unusual mouth movements and shoulder shrugging. His vocal tics on presentation consisted of grunting, squeaking and snorting.
His YGTSS total tic score at initial evaluation was 30 of 50 suggesting moderate symptoms.
The patient denied significant obsessions at the time of the evaluation, but did acknowledge a past history of repeated lock checking, a preoccupation with symmetry and exactness and staring rituals. His OC symptoms were considered "slight." He received a research consensus diagnosis of TS with OC symptoms.
His past medical history was unremarkable with the exception of mild asthma for which he used an inhaler and a history of chronic sinusitis. There was no history of recurrent streptococcal infection.
His developmental history was reportedly unremarkable. There was no evidence of mental retardation or learning disability.
The patient's family history was positive for tics in both parents. The mother reported that as a child she had symptoms similar to those observed in her son. During the proband's initial research evaluation, she was noted by the examiner to have multiple facial tics, but she did not undergo additional diagnostic evaluation.
The patient's father had a long history of vocal and motor tics. He developed tongue biting and chewing at age 9 along with shoulder shrugging and tensing, knee bending, and joint cracking. He continued to have tics of "moderate forcefulness" into adult life and reported only occasional periods of going without motor tics. He noted developing a need to pull the hair on his scalp beginning at age 11 that persisted into adulthood. The only reported vocal tic was throat clearing that developed at age 11 which continued through childhood but was described as absent in adult life.
The patient's father also noted mild OC symptoms beginning at approximately age 9 including preoccupations with ordering and arranging and counting compulsions. In adulthood he noted obsessions with saving papers, feeling that he needed to pray "excessively" and needing to "even things up." His OC symptoms caused no reported distress.
Family 4:
The patient is a Caucasian female evaluated at age 7 for a several year history of throat clearing, shoulder shrugging and eye-blinking. Based on these symptoms and her distress, she was given a clinical diagnosis of TS. She was subsequently enrolled in a multi-center study of TS and underwent research consensus diagnostic evaluation which confirmed the diagnosis and demonstrated she suffered from mild OC symptoms.
These consisted of intrusive thoughts that required her to eat only certain foods and in a specific order. She also reported a preoccupation with ordering and arranging.
The patient's past medical history was uneventful. There was no history of head trauma, seizure, neurological disorder or recurrent streptococcal infection. Her developmental history was unremarkable, with no evidence of mental retardation or learning disability.
No one else in the family carried a formal diagnosis in the TS-spectrum.
However, the patient's mother reported that the proband's sister had suffered from transient throat clearing as a child and, during periods of stress, had what the mother felt was an eye-blinking tic. By history, a paternal uncle suffered from life-long throat clearing and markedly excessive hand washing. The maternal grandfather demonstrated the identical food preoccupations as those identified in the proband, involving ordering and arranging, a need to eat foods one at a time and a marked distain for foods touching each other. The patient's mother noted that she suffered from mild intrusive thoughts including an inability to walk under ladders as well as a preoccupation with hand washing. She noted that these concerns, while not impairing, were ego-dystonic and she felt the need to perform repetitive actions to ward off a negative consequence if she violated one of these "superstitions." 93.4% Caucasian, 2.9% Hispanic, 2.2% African-American, and 1.5% Asian.
B. Materials and Methods

TS
Control Sample: Controls for mutation screening and SNP genotyping were drawn randomly from a group comprised of 2188 ethnically heterogeneous anonymized DNA samples derived from an unrelated project involving acute coronary syndrome (1134 cases/1054 controls). Males accounted for 65.2% of the samples. The self-identified racial distribution was 82.9% Caucasian, 13.6% African-American, and 3.5% other races.
Fluorescence in situ hybridization (FISH)
Studies were undertaken to fine map the chromosome 13 inversion, inv(13)(q31;q33), using FISH as previously described (S1). Bacterial artificial (table S2) . BACs were cultured overnight and DNA was extracted using NucloBond Plasmid Midi Kit (BD Biosciences, San Jose, CA). Probes were hybridized to metaphase spreads to confirm both the centromeric and telomeric extent of each breakpoint. BACs within these intervals were then successively hybridized until overlapping clones were identified as centromeric, spanning, and telomeric to each breakpoint (table S2) .
Amplification of SLITRK1
Genomic sequence for the 5' UTR, coding region, and 3' UTR of SLITRK1 were obtained from the UCSC Genome Browser. Primers flanking amplicons between 400 and 600 base pairs were designed using Primer3 software (http://frodo.wi.mit.edu/cgibin/primer3/primer3_www.cgi) with a minimum overlap of 50 base pairs in order to ensure high quality sequence across the amplified interval (table S3) . PCR amplification was performed in 96/384-well plates, using 50 ng DNA as template in a 20µl reaction.
The standard reaction mixture contained 10µl 2x FailSafe™ Buffer Premix D (Epicentre, Madison, WI), 1µl 10µmol of each primer, 0.05µl cloned Pfu DNA polymerase (Stratagene, La Jolla, CA), and 0.45µl Taq DNA polymerase isolated from an E. coli strain that carries the DNA polymerase gene from T. aquaticus.
Two PCR cycling protocols were used: a standard protocol and an alternate touch down protocol (TD) for difficult to amplify regions. The standard protocol was comprised of a denaturation step at 95°C for 4 min, followed by 30-35 cycles of a 95°C denaturation step for 30 sec, an annealing step at an optimized temperature (table S3) 
Genotyping with Short Tandem Repeat (STR) Markers
Paternity was confirmed using selected STR markers from the ABI PRISM ® Linkage Mapping Set V. 2.5 (Alameda, CA). To test for a common haplotype in the region surrounding SLITRK1, additional STR markers were generated by querying the human genome sequence using the UCSC Genome Browser. BACs in the region of interest were evaluated for repeats containing at least 18 dinucleotide pairs. Primers flanking these potential markers were designed using Primer3 software and one primer from each pair was labeled with either 5-Carboxyfluorescein (5-FAM) or 6-Hexachlorofluorescein (HEX) during synthesis. PCR amplifications were performed using the standard PCR reaction noted above, with a 55°C annealing temperature.
Amplified samples were sent to W.M. Keck Foundation Biotechnology Resource Laboratory (New Haven, CT) for analysis. Genotypes were called manually using GeneMapper® Software V. 3.7 (Applied Biosystems, Foster City, CA).
All tested markers were consistent with reported paternity in families 1 and 4 ( 
Statistical Analysis of var321
We sought to determine the probability of independently observing an identical var321, given the null hypothesis of no association with TS and controlling for mutation screening of all relevant sites in the SLITRK1 gene. We specified a mutation frequency characteristic of CpG dinucleotide sites (1.6 x 10E-7) (S2), of which there are 158 in the entire SLITRK1 transcript including 5 and 3' UTRs. Given the first var321, the conditional probability of a second observation in 346 subsequent alleles is: 1-(1-1.6x 10E-7) 346 = 5.5 x10E-5.
TOPO® Cloning
To confirm the single base deletion and resulting frameshift mutation, amplification of Proband 2 DNA was undertaken with CD-5 primers (table S3) . The PCR product was gel extracted, purified, and then cloned with the TA Cloning® Kit (Invitrogen, Carlsbad, CA). Clones were sequenced on both strands at the W.M. Keck Foundation Biotechnology Resource Laboratory.
As part of our analysis of haplotypes surrounding var321, we evaluated a unique 
Sequencing Gel of Frameshift Variants
Frameshift variants were amplified with the following primers: F: 72°C for 3 min. PCR products were analyzed using denaturing polyacrylamide gel electrophoresis.
SNP Genotyping
SNP genotyping was performed using the Sequenom MALDI-TOF MS system (S3). Primers for PCR amplification and primer extension reaction were designed using Spectrodesigner software (Sequenom, San Diego, CA) (table S5) 
Human SLITRK1 3'UTR Luciferase and cDNA Constructs
The full-length 3' UTR of SLITRK1 containing the wild type or var321 allele was amplified using forward primer TACTGGCACAATGGGCCTTAC and reverse primer CTGTCATGAAATGCAGTCCACA. The 3' UTR of Renilla luciferase in the vector pRL-SV40 (Promega, Madison, WI) was excised using restriction enzymes XbaI and BamHI and replaced with the full-length 3'UTR of SLITRK1. The resulting constructs (pRL-wt SLITRK1-3'UTR and pRL-mut SLITRK1-3' UTR) were verified by sequencing.
Full length wild type and frameshift human SLITRK1 were PCR amplified from control or patient samples. respectively, and cloned into a pCLEG plasmid. The resulting constructs were verified by direct sequencing.
Luciferase Assays
N2a cells were plated on poly-L-ornithine coated Costar® 24-well cell culture plates (Corning Inc., Acton, MA) at 5. The dual-luciferase reporter assay (Promega) was used according to manufacturer's protocol. Twenty-four hours after transfection, cells in each well were lysed using 100 µl of passive lysis buffer and 20 µl of the lysate was used for the assay.
Measurements were taken using the TD-20/20 luminometer (Turner Designs, Sunnyvale, CA).
Statistical analysis was performed for each quantity of miRNA using the nonparametric Mann-Whitney U test. Area-under-the-curve (AUC) for relative luciferase ratios across each of the quantities of miRNA-189 was determined by summing the following formula across 6 replicates each at 4 different quantities of miRNA (20pmol, 5pmol, 1pmol, 0.2pmol) and was found to be significant (p=0.002) AUC = 15*0.5*(luciferase 20pmol + luciferase 5pmol ) + 4*0.5*(luciferase 5pmol + luciferase 1pmol )+0.8*0.5*(luciferase 1pmol + luciferase 0.2pmol ). The raw luciferase data are presented in table S8.
In Situ Hybridization
Experiments were carried out in accordance with an IACUC approved protocol at the Yale University School of Medicine. P9 and P14 mouse brains were fixed by intracardiac perfusion with 4% paraformaldehyde and sectioned at 36 µm using a sledge microtome. In situ hybridization of mouse and human brain tissue was performed as previously described with minor modifications (S4, S5). RNA probes complementary to mouse Slitrk1 (bases 322 to 1383 of the mouse Slitrk1 cDNA, NM_199065) were prepared and labeled with digoxigenin-11-UTP. The mouse SLITRK1 sequence in the probe region is more than 90 percent identical to the human sequence.
To detect miR-189, a double-stranded template was generated by annealing two oligonucleotides (anti-sense miRNA-189:
GTGCCTACTGAGCTGATATCAGTTTTCCTGTCTC; T7 promoter GTGCCTACTGAGCTGATATCAGTTTTCCTGTCTC) and filling in with Klenow. The miR-189 probe was prepared from this template and labeled with digoxigenin-11-UTP, then purified by ethanol precipitation in the presence of 0.5 M ammonium acetate. In situ hybridization was performed as described (S5) 
In Utero Electroporation, Primary Neuronal Cell Cultures and Immunostaining
All surgeries were performed under sterile conditions as described (S6) 
Quantitative Analysis of Dendrites
The quantitative analysis of dendritic growth was carried out in a blinded fashion such that neither the treatment condition nor the DIV stage were known to the person reconstructing the neurons. Only neurons with a pyramidal morphology and with readily distinguishable, unobstructed dendrites were analyzed. Twenty four to fifty GFPimmunopositive neurons within each condition (GFP, GFP+ wt SLITRK1, and GFP+ mut (table S9) . Statistical analysis was carried out using the 2-tailed Student's t-test with a significance level of p<0.05. Table S1 . Markers used to confirm paternity in Families 1 and 4. Table S8 . Raw data and relative luciferase activity for luciferase reporter assay in N2a cells. 
Genotypes
